PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA: A RANDOMISED PLACEBO -CONTROLLED DOUBLE-BLIND PHASE III TRIAL OF METFORMIN IN HIV-INFECTED PERSONS WITH PRE-DIABETES

Project Information

The META Trial

Grant agreement ID: 101145764

DOI

10.3030/101145764

EC signature date 5 March 2024

Start date 1 January 2025

End date 31 December 2026

Funded under

• Health

Total cost

€ 1 811 067,50

EU contribution

€ 1 811 067,50

Coordinated by

FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Process Evaluation of a Metformin RCT for People Living with HIV with Pre-Diabetes in Tanzania (META Trial): a study protocol

Author(s): Nandakumar Ravichandran, John Broughan, Geoff McCombe, Sheila Loughman, Sokoine Kivuyo, Faith Aikaeli, Doreen Pamba, Erik Van Widenfelt, Magreth Mbena, Jeffrey V Lazarus, Sayoki Mfinanga, Kaushik Ramaiya, Shabbar Jaffar, Anupam Garrib, Walter Cullen
Published in: HRB Open Research, Issue 8, 2025, ISSN 2515-4826
Publisher: F1000 Research Ltd
DOI: 10.12688/HRBOPENRES.14251.1